Genomenon is a pioneering genomic health IT company that is at the forefront of advancements in genomics. They bridge the gap between cutting-edge research and patient DNA to facilitate the diagnosis and treatment of individuals affected by rare genetic diseases and cancer. At the core of their offerings is the Mastermind Genomic Search Engine, the world's only comprehensive genomic-specific search engine.

This revolutionary technology is used by numerous genetic labs globally to expedite diagnoses, boost diagnostic yield, and ensure consistency in reporting genetic testing results. Moreover, Genomenon's Mastermind Genomic Landscapes support pharmaceutical and bio-pharma companies in precision medicine development, clinical trial target selection, and CDx regulatory submissions. Founded out of the need for faster and more comprehensive variant interpretation, Genomenon combines expert curation with unique machine learning methods to extract the most relevant information from billions of dollars' worth of medical literature.

Today, their groundbreaking technology empowers scientists, researchers, and doctors worldwide to more effectively understand diseases at a molecular level and provide personalized treatments